AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025
Oct 16, 2025
33148_dirs_2025-10-16_f8b16e1a-a122-4a18-a3dd-291c1ffce95f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-10-14
Reporting Person: Militello John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-14 | Common Stock | S | 19841 | $3.96 | Disposed | 76083 | Direct |
| 2025-10-14 | Common Stock | S | 5514 | $3.965 | Disposed | 70569 | Direct |
| 2025-10-14 | Common Stock | S | 3005 | $3.97 | Disposed | 67564 | Direct |
| 2025-10-14 | Common Stock | S | 558 | $3.975 | Disposed | 67006 | Direct |
Footnotes
F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20